, page-4. Commodities. Last edited by ejjwj: 28/06/23. Appendix 4C - quarterly There are thousands of people out there with IXC shares, you simply can not predict when one is going to sell and how much they are going to sell. Expand. Webinvest Pty Ltd<Olsb Unit A/C>. ASX - Day Trading. Forums. IXC is at base, so it’s just a matter of when it’ll leave base and start turning to the upside. ASX - Day TradingAnother day…another approval. Timeline Annotations of the IXC Chart Story Thus Far - IXC IPO'd in mid 2019 with Phase II data due Mid 2020, stock performs very well on IPO with tight T20 - The stock rose in anticipation for the Mid 2020 Phase II data read out in early 2020 - Before crashing alongside the Covid 19 Market Crash Hysteria in March 2020 AND all volume the last 18 months has led to a higher T20 ownership) meanwhile we have a mere 3 posts regarding an IXC job listing for a CMO that's description can be interpreted as hinting at a second indication. Created with Sketch. . Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. 3¢. Loading. 1. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. Appendix 4C - quarterly* or having a go at doing so, page-30. . 0 Great. is there any news release, or SP increasing due to only the market showing interest, page-2. Interexchange carriers (IXCs) own or share the various high-bandwidth, fiber-optic trunk lines that cross the country and provide high-speed switched digital services for voice, data, and video communication. Latest Posts. ASX - By Stock. Join the HotCopper ASX share market forum today for free. ASX - By Stock. ASX - By Stock. Appendix 4E and Annual Report, page-3. 3¢. Some people like to gamble on stocks, others invest. ASX - By Stock. Learn how it impacts everything we do. Forums. ASX - Day TradingI sold around half my shares yesterday at 25c. 59). Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Top 20 remains holding 58% compared to 58. , page-3. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Created with Sketch. I'm thinking of flying there myself!Prof Alex Sinclair is to present in Melbourne and Sydney next. IXC Price at posting. 1950. ASX - By Stock. Created with Sketch. ASX - Day TradingApril 20 (Reuters) - Invex Therapeutics Ltd (IXC) : MINISTRY OF HEALTH APPROVAL FOR IIH EVOLVE CLINICAL TRIAL IN ISRAELInvestor Presentation, page-2. Forums. . Created with Sketch. ASX - Day TradingAlthough with IXC fully cashed up it makes this fall irrational and the odd one out of alot of these small cap speccies that are death spiralling - aka, opportunity . Share Not unexpected. Created with Sketch. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. . 26 area could be wrong and it could go for example to $3. With a team of 68. IXC has not had a decent bounce at all as yet, maybe still some sellers lurking. ASX - General. Forex. IXC Price at posting: 37. Latest Posts. ASX - By Stock. 333334. In 2005, IIH cost the American health care. Target our investor community with our suite of Hotcopper Advertising opportunities. rights. gov and there is lots of good information about the trial. View daily, weekly or monthly formats back to when Invex Therapeutics Ltd stock was issued. . ASX - Day TradingCreated with Sketch. ASX - Day TradingA new thread to put trading comments / reasoning / opinions in. Below is the broker data for IXC November to. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. 30 is a good sign as well. Advertise on HotCopper. Currency in USD 38. 2 years ago biotech stocks were in vogue and hence NEU was fairly priced at $1. . We are a team of expert financial advisers each specialising in different, yet complementary areas. 30 to $15 in the space of 1 and half years Bios move fast when value is recognised. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. Join the HotCopper ASX share market forum today for free. Notice of Investor Call and Presentation, page-3. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportA new thread to put trading comments / reasoning / opinions in. ASX - Day TradingCreated with Sketch. Created with Sketch. 6million shares?, and if so is anyone worried about this, release date 29th. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. Read in the announcement, has changed name and he has bought more ixc, page-2. Market open. More progress made towards the start of Phase III, we have now made it on to the clinicltrials. Created with Sketch. ASX - Day Trading0. IXC Price at posting:. Advertise on HotCopper. Hi Hot Copper, this will be a master thread for my daily posting of the Pharma Market Watchlist, please only keep commentary to the watchlist. Anyone had a look at this or put an application in for some stock in the IPO?Created with Sketch. **Close price adjusted for splits and dividend and/or capital gain distributions. Trading HaltDCF Valuation: IXC Intrinsic Value of $6. 3¢. . ASX - Day TradingI bought some today at 44. . boolish Jellyroll hey. 7KB AVG: 22/11/2023 1:08 PM : 2023 AVG AGM Addresses and Presentation 35 pages 3. Here come the vultures. I guess that&amp;apos;s why retail performs so poorly on average, so many think they are long term investors but can&amp;apos;t hold onto their shares for more. Very tempted to buy them back today at 19c. Join the HotCopper ASX share market forum today for free. Created with Sketch. Created with Sketch. Market . . Charts. When can we expect some update or. Forums. Created with Sketch. IXC Price at posting: 79. is there any news release, or SP increasing due to only the market showing interestCreated with Sketch. 1. ASX - Short Term Trading. A new thread to put trading comments / reasoning / opinions in. 5¢ Sentiment: Buy Disclosure: Held Created with Sketch. ASX - Day TradingHi all, I would like to preface the below summary written prior to the research links as being a heavily simplified summary of the company and the. Sentiment for Invex Therapeutics Ltd. Created with Sketch. Last edited by jellyroll: 27/02/23. ASX - Day TradingIf anyone told me a year ago, "there is a chance IXC cant progress the trial and the management all get sacked" I would agree that there was a chance, but nullified to a 1-2% black swan and worth the upside return profile. ASX - By Stock. Invex Therapeutics Lists on ASXNo worries mate :), page-15. Charts. . Created with Sketch. We are supported by a Board of Advice which is made up of the premier leaders in the various fields in which we, Private Capital Advisers, specialise. Australian finance news, stock quotes, currency information and blogs0. . . Share IXC needs to be proactive and release a statement. Latest Posts. . ASX - By Stock. HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. Created with Sketch. Also took placement stock @$1. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. EGREcoGraf partners with VinES Energy for pioneering Battery Anode Material Facility in Vietnam. . I knew zero about the fundamentals of IXC. ASX - Day Trading. ASX - Day TradingChange in substantial holding. 59 before first real pull back (those lines will be used in the future, they always set it up for that reason, being $3. Anyone buying now can carry to $5 and then sell a few prior to readout as insurance against losing everything in the coin flip. Bumping up this thread as $3. is there any news release, or SP increasing due to only the market showing interestInvex Receives UK Approval to Commence Phase III TrialInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Created with Sketch. 1950. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. Created with Sketch. Very impressive. Invex to Present at Virtual ASX Small and Mid-Cap ConferenceHealth & BiotechMay 24, 2020|Tim BorehamSHAREFrom the bulging file of Nasty Obscure Diseases we present idiopathic intracranial hypertension (IIH), a. Withdrawal of AGM Resolutions, page-2. Latest Posts. , page-4. IXC Price at posting: 45. , page-3. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentNotice of Annual General Meeting/Proxy Form. Created with Sketch. IXC Price at posting: 38. Invex Therapeutics Lists on ASX, page-3. ASX - Day TradingInvex Files Pre-IND/Type B Meeting Request with US FDA, page-2. 5¢ Sentiment: Hold Disclosure: Held IXC Valuation Report MST. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Created with Sketch. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. ASX - By Stock. A neurosurgeon from Mercer Island and a noted mountaineer from Spokane, Washington, were killed on February 4, 1986, when. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. (IXC) - see HotCopper and other bloggers' predictions - TipRanks. Most bio's get. AVALANCHE. Click for more information. Created with Sketch. Market . , page-4. HotCopper has news, discussion, prices and market data on IXUP LIMITED. ASX - By Stock. Created with Sketch. 5mill options have been issued at a strike price of $1 First lot 250k to a soph. At that time the total costs of IIH exceeded $444,000,000. . ASX - Day Tradingis invex releasing 2. . Last updated 10. 5% last year. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. Ionic Rare Earths Limited is an Australia-based company that is focused on investment in. , page-2. Created with Sketch. Cannot wait. Daily bounced well off support and now slowly creeping upId like to see a range develop now between say 18 - 23 before next bit of news, page-517. Advertise on HotCopper. . , page-2. Will management look for an early exit or are they wanting to take to market? Just came across IXC from another stock @JabraD posts on. 5¢ Sentiment: Buy Disclosure: HeldAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Lots of possible reasons for this - but regardless, it points to Tom knowing that there is upside to this current SP. Should jump back in Titans, was good having you on board as you know your stuff IXC Price at posting: 57. Latest Posts. 0. 79 -0. I think having this out we can discuss on the way. 5¢ Sentiment: Buy Disclosure: Held. Hopefully that placement overhang will be removed today tomorrow and the share price will catch up. Latest Posts. . Charts. Created with Sketch. Created with Sketch. ASX - By Stock. Forgot Client ID or Password? If you're a CommBank customer, you can access CommSec from Netbank. Notice of Quarterly Investor Call. Invex Receives Approval for Paediatric Plan from the EMA, page-3. Latest Posts. IAMIncome Asset Management to boost bond sales through partnership with Netwealth. . Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. ASX - Day TradingCreated with Sketch. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumIXC need to hold a conference call to discuss the announcement - they need to front up. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Created with Sketch. Learn more. Share Would anyone know whether the 28c cash backing strips out all of the options listed in the notice? or is it included and they will fall away on strike dates?wonder if the GLP-1 agonist referred to in this media release. IXC Valuation Report MST. 26 area could be wrong and it could go for example to $3. As thread states post your questions here and let’s start compiling a list. Ceasing to be a substantial holder. Created with Sketch. 0. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only a handful of posts discussing the fundamental analysis of the business itself,Publication of Invex IIH Phase II Pressure Trial Results. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. ASX - By Stock. RAC went from 30 cents to $4 in the space of 5 months PAR went from 30 cents to $4 in the space of 1 and half years NEU went from $1. Theres alot of breakdowns above that are yet to be backtested. Market . . Invex Receives Approval for Paediatric Plan from the EMA, page-3. Withdrawal of AGM ResolutionsInvex Granted Key European Patent for Exenatidehe’s known for the vend etc like asxcowboy has pointed out. Thought that this would be worthy of its own thread, a great starting place for those new to IXC and arguably the best presentation to date, Worth a. Last updated 10. Created with Sketch. 0. Company has options because they have cash. sentiment based on opinions from HotCopper and others. Created with Sketch. Invex Files Pre-IND/Type B Meeting Request with US FDAIXC is a long term play mate, not a daytraders plaything as too illiquid. ASX - By Stock. 4. ASX - By Stock. Of course IXC isnt the stock market but its coincidental that selling has stopped around this 17 cents mark which aligns with the old trend line from back in the days. ASX - By Stock. , page-35. 6B TAM that is unencumbered and a 55% peer average neurology success rate from Phase 3!IXC although only the 1 indication has already raised the sufficient cash to go all the way, they are in phase 3 trials, they have a time line and are full steam ahead. We are a team of expert financial advisers each specialising in different, yet complementary areas. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-7. wonder if the GLP-1 agonist referred to in this media release. Latest Posts. Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited)At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. ASX - Day Trading. Advertise on HotCopper. Join HotCopper today. ASX - By Stock. Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. IXC is at base, so it’s just a matter of when it’ll leave base and start turning to the upside. A promising development for IXC, a company with a current Phase III trial that is expected to finish dosing in 12 months time, We hear from a patient from the Phase II trial completed 2 years ago, with our current Phase III trial ongoing as we speak: Tony Grist - 5th largest holder in IXC Tom Henderson - 2nd largest holder in IXC Kim Hogan - 6th largest holder in IXC and now Simon Joyner - 14th largest holder in IXC Just a background of this board of advice. Created with Sketch. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. IXC below Example of that is NEUInvestor Presentation, page-3. . Appreciate your input Dr T. Login to your CommSec account to buy. . ASX - By Stock. ASX - By Stock. . 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. 7% #asx #ausbiz 23 Jun 2023 06:06:11Not been following IXC but it seems that this Orphan Drug Designation for TBI now have $0 value due to the other Phase III trial update and the company is. How many friends and family got out after the last announcementshould have been released at the same time, page-34. ASX - Short Term Trading. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. Both approaches can work, but it is not wise to confuse the two. Im not expecting anything out of the ordinary apart from the fact thats its overdone and too undervalued at the stage its at. Latest Posts ForumsiShares Global Energy ETF (IXC) Add to watchlist NYSEArca - Nasdaq Real Time Price. Backed by Twiggy. 6% $DLM 50. Just a matter of time really. 333334. 4KB OECCreated with Sketch. , page-17. View daily, weekly or monthly formats back to when Invex Therapeutics Ltd stock was issued. Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. Join the HotCopper ASX share market forum today for free. I think having this out we can discuss on the way. , page-20. Created with. , page-3. ASX - By Stock. Created with Sketch. Created with Sketch. Is it just me or has IXC gone very quiet. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentHREC and TGA Approval to Commence Phase 3 in AustraliaHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. IXC (ASX) Ann: Trading Halt - HotCopper. 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. Also took placement stock @$1. Latest Posts. Invex Therapeutics Ltd. Latest Posts. ASX - General. Market open. Global Phase 3 Trial of Presendin to Launch in Q4 2021Invex receives IND approvalInvex Receives Written Response from FDA on Type C Meeting, page-2. INVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC IXC chart IXC invex therapeutics ltd IXC chart 1 Last ralom 17,015 Posts. Report Created with Sketch. Thought Id reshare as both now into phase 3 trials fully funded (please bare in mind 2. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentCreated with Sketch. ASX - Day TradingIf IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. Market . Created with Sketch. Invex Therapeutics Ltd. Created with Sketch. Created with Sketch. ASX - By Stock. Share Ok news not the greatest but I dont think its as bad as people gonna re-act (mainly retailers) Primary endpoint remains unchanged Protocol changes focus on reordering secondary endpoints - replacing PMD with the more. . 0. Forums. HotCopper has news, discussion, prices and market data on IONIC RARE EARTHS LIMITED. 3. 1. 1073084. ASX - Day TradingInitial FDA and EMA Advice on Presendin Development, page-2. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. ASX - Day TradingHere's a very good opportunity for people in Sydney. . 31% more bullish than other Healthcare sector stocks. Invex Receives Approval for Paediatric Plan from the EMA, page-2. . ASX - Short Term Trading. Initial FDA and EMA Advice on Presendin Development, page-3. Proposed Capital Return to Shareholders of $14. Management have earmarked this a significant milestone - given they previously tied it to performance. Cold Comfort Ice Cream Company, Victoria, British Columbia. Last research or update on this I listened to was by FiftyOneCapital. 76 (-1. June 29 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX RECEIVES UK APPROVAL TO COMMENCE PHASE III TRIAL CLINICAL TRIAL FOR PRESENDIN DRUG FOR. . Target our investor community with our suite of Hotcopper Advertising opportunities. Both approaches can work, but it is not wise to confuse the two. Created with Sketch. . 31% more bullish than other Healthcare sector stocks. Market Cap $102. Folks say we are pioneers of craft ice cream in Victoria. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportMarch 20 (Reuters) - Invex Therapeutics Ltd (IXC) : APPROVAL TO COMMENCE IIH EVOLVE PHASE III CLINICAL TRIAL RECEIVED FROM BUNDESINSTITUT FÜR. 19 Per share (Personal Estimate) vs MST Research report of $3. . ASX - Day Trading It is certainly an interesting case study regarding management strategy; that noted strategy would work during fair or bullish markets as participants are acting rationally (and by sticking to their knitting during Covid Crash the IXC share price bounced back heavily with Phase II results - so perhaps thats what they were thinking would happen. . Discover historical prices for IXC. Re-purposed FDA drug for other illness with amazing effect as domenstrated in P2 results which ever drove sp to $2. 0% $ODM 35. ASX - Day TradingCreated with Sketch. Forums. This is fantastic news and I appreciate the fact that it has not been heavily hyped by the company, makes you wonder what else is being worked on. Reply.